ONL Therapeutics

London-based vaccine company Vicebio Ltd. has become the 17th company this year to raise a nine-figure series B round, according to Evaluate data. TCGX led its $100m series B venture capital round,

Derived from Strategic Transactions , Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging bio

Set on saving photoreceptors in the eye 820 Heather Way Ann Arbor, MI 48104 Phone: (734) 223-2095 Contact: David Zacks, MD, PhD Industry Segment: Ophthalmology Drugs Business: Treatments for retinal d

The New Ophthalmic Drug Players Unmet medical need and market size continue to drive venture investors to ophthalmic drug plays focused on diseases that blind. This interest is fueled by a stable pool